These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 861349)

  • 1. Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of the thyroid.
    Calmettes C; Moudktar MS; Milhaud G
    Biomedicine; 1977 Mar; 27(2):52-4. PubMed ID: 861349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
    Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
    Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
    Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
    Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ; Iglesias P
    Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumours markers. Calcitonin and carcinoembryonic antigen in medullary carcinoma of the thyroid (author's transl)].
    Calmettes C; Moukhtar MS; Milhaud G
    Presse Med (1893); 1979 Dec; 8(48):3947-50. PubMed ID: 530945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S; Lazzara S; Palmeri R; Belnome N; Calbo L; Dattola P; Melita P
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H
    Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
    Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
    Norton JA; Doppman JL; Brennan MF
    Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of octreotide in the treatment of medullary thyroid carcinoma.
    Frank-Raue K; Ziegler R; Raue F
    Horm Metab Res Suppl; 1993; 27():44-7. PubMed ID: 8330871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of pentagastrin and calcium as thyrocalcitonin secretagogues in the early diagnosis of medullary carcinoma of the thyroid gland.
    Linehan WM; Farrell RE; Cooper CW; Wells SA
    Surg Forum; 1977; 28():110-2. PubMed ID: 617389
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
    Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
    Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
    Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
    Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor markers in C-cell cancer].
    Raue F; Schmidt-Gayk H; Ziegler R
    Dtsch Med Wochenschr; 1983 Feb; 108(8):283-7. PubMed ID: 6297868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.
    Koizumi M; Watari T; Hirabayashi K
    Ann Nucl Med; 1993 Feb; 7(1):53-6. PubMed ID: 8461239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
    Pichon MF; Coquin G; Fauveau C; Rey A
    Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of the assay of plasma carcinoembryonic antigen and thyrocalcitonin in the detection of medullary cancer of the thyroid with amyloid stroma. Results of a familial survey of 47 subjects].
    Allanic H
    Ann Med Interne (Paris); 1984; 135(5):341-4. PubMed ID: 6486613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.